Loading…
NSE · Source: NSE
As disclosed by the issuer.
| KPI | Value | Period | Pages |
|---|---|---|---|
| Revenue from Operations | ₹9,274.39 lakhs / ₹22,550.44 lakhs / ₹18,588.27 lakhs / ₹11,797.38 lakhs | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 107 |
| Total Revenue | ₹9,351.37 lakhs / ₹23,519.93 lakhs / ₹18,634.07 lakhs / ₹11,941.52 lakhs | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 107 |
| EBITDA | ₹898.54 lakhs / ₹2,588.66 lakhs / ₹3,300.88 lakhs / ₹1,525.85 lakhs | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 107 |
| EBITDA Margin | 9.61% / 11.01% / 17.71% / 12.78% | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 107 |
| PAT Margin | 5.81% / 6.91% / 11.33% / 8.25% | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 107 |
| Debt / Equity | 0.32x / 0.24x / 0.03x / 0.24x | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 108 |
| Interest Coverage Ratio | 9.41x / 22.42x / 27.15x / 30.12x | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 108 |
| RoE | 4.72% / 21.01% / 34.57% / 24.66% | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 108 |
| RoCE | 5.59% / 25.47% / 49.13% / 27.83% | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 108 |
| Net Debt / EBITDA | 3.41x / 0.13x / 0.01x / 0.42x | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 108 |
| Current Ratio | 2.65x / 2.42x / 2.20x / 1.19x | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 108 |
| Cash & Equivalents as presented in KPI table | ₹593.24 lakhs / ₹1,490.96 lakhs / ₹176.54 lakhs / ₹321.86 lakhs | Apr-Sep 2023 / Fiscal 2023 / Fiscal 2022 / Fiscal 2021 | 108 |
Stallion India Fluorochemicals Limited, incorporated in 2002, specializes in the sale of refrigerant and industrial gases. The company operates four facilities across Maharashtra and Rajasthan, focusing on the processing and blending of gases for various applications, including air conditioning and pharmaceuticals.
The Indian fluorochemicals and specialty gases market is expected to reach approximately 675-725 million USD by 2029, driven by rising demand from sectors like electronics and healthcare. Government initiatives such as 'Make in India' are further stimulating growth in this sector.